Sagimet Biosciences (NASDAQ:SGMT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Sagimet Biosciences (SGMT) operate in?

Sagimet Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Sagimet Biosciences Stock (NASDAQ: SGMT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.43M
Day Range	- - -
52 Wk Range	2.39 - 20.71
Market Cap	$150.67M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	15.48%
Days to Cover	5.09

Recent News

This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

What's Going On With Sagimet Biosciences Stock On Thursday?

Sagimet Biosciences shared promising data from its FASCINATE-2 Phase 2b trial of denifanstat at the EASL Congress.

Vandana Singh

What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?

Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment. Further trials needed to confirm efficacy and safety.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.43M
Day Range	- - -
52 Wk Range	2.39 - 20.71
Market Cap	$150.67M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	15.48%
Days to Cover	5.09

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Sagimet Biosciences (SGMT) stock?

You can purchase shares of Sagimet Biosciences (NASDAQ:SGMT) through any online brokerage.

View our list of the best stock brokerages

Who are Sagimet Biosciences (SGMT) competitors?

Other companies in Sagimet Biosciences’s space includes: Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE), Atossa Therapeutics (NASDAQ:ATOS), PepGen (NASDAQ:PEPG) and Adaptimmune Therapeutics (NASDAQ:ADAP).

What is the forecast, or price target, for Sagimet Biosciences (SGMT) stock?

Sagimet Biosciences has a consensus price target of $29.17.

What is the current price for Sagimet Biosciences (SGMT)?

The stock price for Sagimet Biosciences (NASDAQ: SGMT) is $4.68 last updated November 20, 2024 at 6:44 PM EST.

Does Sagimet Biosciences (SGMT) pay a dividend?

There are no upcoming dividends for Sagimet Biosciences.

When is Sagimet Biosciences (NASDAQ:SGMT) reporting earnings?

Sagimet Biosciences’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is Sagimet Biosciences (SGMT) going to split?

There is no upcoming split for Sagimet Biosciences.

What sector and industry does Sagimet Biosciences (SGMT) operate in?

Sagimet Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Sagimet Biosciences

Sagimet Biosciences (SGMT) Forecast